Reply to C.L. Braal et al, H. Brauch et al, and M.P. Goetz et al

Henk-Jan Guchelaar¹, Anabel Sanchez-Spitman¹, Vincent Dezentjé¹+4

• ¹Henk-Jan Guchelaar, PharmD, PhD and Anabel Sanchez-Spitman, PharmD, Leiden University Medical Center, Leiden, the Netherlands; Vincent Dezentjé, MD, PhD, Netherlands Cancer Institute/Antoni van Leeuwenhoek, Amsterdam, the Netherlands; Stefan Böhringer, PhD, MD and Jesse Swen, PharmD, PhD, Leiden University Medical Center, Leiden, the Netherlands; Patrick Neven, MD, PhD, University Hospitals Leuven, Leuven, Belgium; and Hans Gelderblom, MD, PhD, Leiden University Medical Center, Leiden, the Netherlands.